<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Cheung JW</submitter><funding>Michael Wolk Heart Foundation</funding><funding>NCATS NIH HHS</funding><funding>Clinical and Translational Science Center at Weill Cornell Medicine</funding><funding>New York Cardiac Center, Inc.,</funding><funding>NIH</funding><funding>New York Weill Cornell Medical Center Alumni Council</funding><pagination>3035-3043</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7963138</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>40(36)</volume><pubmed_abstract>&lt;h4>Aims&lt;/h4>Although catheter ablation has emerged as an important therapy for patients with symptomatic atrial fibrillation (AF), there are limited data on sex-based differences in outcomes. We sought to compare in-hospital outcomes and 30-day readmissions of women and men undergoing AF ablation.&lt;h4>Methods and results&lt;/h4>Using the United States Nationwide Readmissions Database, we analysed patients undergoing AF ablation between 2010 and 2014. Based on ICD-9-CM codes, we identified co-morbidities and outcomes. Multivariable logistic regression and inverse probability-weighting analysis were performed to assess female sex as a predictor of endpoints. Of 54 597 study patients, 20 623 (37.7%) were female. After adjustment for age, co-morbidities, and hospital factors, women had higher rat</pubmed_abstract><journal>European heart journal</journal><pubmed_title>Sex-based differences in outcomes, 30-day readmissions, and costs following catheter ablation of atrial fibrillation: the United States Nationwide Readmissions Database 2010-14.</pubmed_title><pmcid>PMC7963138</pmcid><funding_grant_id>UL1 TR002384</funding_grant_id><pubmed_authors>Cheung JW</pubmed_authors><pubmed_authors>Markowitz SM</pubmed_authors><pubmed_authors>Kim LK</pubmed_authors><pubmed_authors>Liu CF</pubmed_authors><pubmed_authors>Lerman BB</pubmed_authors><pubmed_authors>Yeo I</pubmed_authors><pubmed_authors>Thomas G</pubmed_authors><pubmed_authors>Christos PJ</pubmed_authors><pubmed_authors>Ip JE</pubmed_authors><pubmed_authors>Kamel H</pubmed_authors><pubmed_authors>Cheng EP</pubmed_authors><pubmed_authors>Wu X</pubmed_authors></additional><is_claimable>false</is_claimable><name>Sex-based differences in outcomes, 30-day readmissions, and costs following catheter ablation of atrial fibrillation: the United States Nationwide Readmissions Database 2010-14.</name><description>&lt;h4>Aims&lt;/h4>Although catheter ablation has emerged as an important therapy for patients with symptomatic atrial fibrillation (AF), there are limited data on sex-based differences in outcomes. We sought to compare in-hospital outcomes and 30-day readmissions of women and men undergoing AF ablation.&lt;h4>Methods and results&lt;/h4>Using the United States Nationwide Readmissions Database, we analysed patients undergoing AF ablation between 2010 and 2014. Based on ICD-9-CM codes, we identified co-morbidities and outcomes. Multivariable logistic regression and inverse probability-weighting analysis were performed to assess female sex as a predictor of endpoints. Of 54 597 study patients, 20 623 (37.7%) were female. After adjustment for age, co-morbidities, and hospital factors, women had higher rat</description><dates><release>2019-01-01T00:00:00Z</release><publication>2019 Sep</publication><modification>2025-04-26T00:47:50.792Z</modification><creation>2025-04-06T09:48:45.644Z</creation></dates><accession>S-EPMC7963138</accession><cross_references><pubmed>30927423</pubmed><doi>10.1093/eurheartj/ehz151</doi></cross_references></HashMap>